Skip to main content
. 2018 Aug;10(8):5010–5022. doi: 10.21037/jtd.2018.07.09

Figure 3.

Figure 3

The forest pot and TSA of the odds ratio of bevacizumab-associated thromboembolism events. (A) The forest pot for meta-analysis of the ORs of bevacizumab-associated thromboembolism events; (B) Z-curve crossed the trial sequential monitoring boundary for hazard (red dotted curve) and the required sample size based on TSA (n=3,687), entering the area of hazard (above the upper red line). OR, odds ratio; CI, confidence interval; TSA, trial sequence analysis.